Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'leu31 pro34 neuropeptide y human rat'

Search results for: 'leu31 pro34 neuropeptide y human rat'

Items 31-40 of 67

Page
per page
  1. BMS-303141
    B1079 BMS-303141
    Target: ATP Citrate Lyases
    Summary: ATP-citrate lyase inhibitor,potent
      ≥21.2 mg/mL
  2. Thiamet G
    B2048 Thiamet G
     1 Citation
    Target: O-GlcNAcase
    Summary: O-GlcNAcase inhibitor, potent and selective
      ≥100 mg/mL
  3. Fenofibrate
    B1943 Fenofibrate
     1 Citation
    Summary: PPARα agonist
      insoluble in H2O; ≥12.75 mg/mL
  4. AM966
    A3170 AM966
     2 Citation
    Target: LPA Receptors
    Summary: LPA1 antagonist, oral active, high affinity, selective,
      ≥24.55 mg/mL
  5. ARRY-380
    A8366 ARRY-380
    Target: HER2
    Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor
      ≥28.5 mg/mL
  6. SCH 527123
    A3802 SCH 527123
     5 Citation
    Target: CXCR
    Summary: CXCR1 and CXCR2 receptors antagonist
  7. Medroxyprogesterone acetate
    B1510 Medroxyprogesterone acetate
    Target: Progesterone Receptors
    Summary: Steroidal progestin
  8. Pitolisant hydrochloride
    A3727 Pitolisant hydrochloride
    Summary: Nonimidazole inverse agonist
      ≥16.6 mg/mL
  9. Salinosporamide A (NPI-0052, Marizomib)
    A4010 Salinosporamide A (NPI-0052, Marizomib)
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      Soluble in DMSO
  10. Primaquine Diphosphate
    B1820 Primaquine Diphosphate
    Summary: antimalarial agent,blocks protein synthesis
      insoluble in EtOH; ≥18.85 mg/mL

Items 31-40 of 67

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 65item
  2. Lab Reagents 1 item
Reversibility
  1. Reversible 8item
  2. Irreversible 3item
Target
  1. Proteasome 3item
  2. Cathepsins 2item
  3. Histone Deacetylases (HDACs) 1 item
  4. CXCR 1 item
  5. Raf 1 item
  6. mTOR 1 item
  7. MMP 1 item
  8. GSK-3 1 item
  9. Factor Xa 1 item
  10. LPA Receptors 2item
  11. PLK 1 item
  12. VEGFR 1 item
  13. Bromodomain-containing proteins(BRDs) 1 item
  14. MEK 1 item
  15. CGRP receptors 1 item
  16. Smoothened 2item
  17. RARs 1 item
  18. ATP Citrate Lyases 1 item
  19. Microtubules/Tubulins 2item
  20. EGFR 3item
  21. ROCK 2item
  22. Progesterone Receptors 1 item
  23. CFTR 1 item
  24. ErbB 2item
  25. Calpains 1 item
  26. O-GlcNAcase 1 item
  27. Trypsins 1 item
  28. HER2 1 item
  29. DGAT 1 item
  30. Melanocortin (MC) Receptors 1 item
  31. RSK 1 item
  32. Free Fatty Acid Receptors 1 item
  33. CK2 1 item
  34. Melatonin Receptors 1 item
  35. P2X Receptors 1 item
  36. NPY Receptors 1 item
  37. Leukotriene and Related Receptors 1 item
  38. Histamine H1 Receptors 1 item
  39. Phospholipases 1 item
  40. HIV-1 reverse transcriptase 1 item
  41. Catechol O-Methyltransferase (COMT) 1 item
  42. Aldosterone receptor 1 item
  43. DPP-4 1 item
  44. DREADD Ligands 1 item
  45. ADAMs 1 item
  46. human lyase 1 item
  47. PPAR 1 item
  48. MSK 1 item
  49. FXR 1 item
  50. Substance P/NK1 Receptor 1 item
  51. MTH1 1 item
Related Disease
  1. Breast Cancer 12item
  2. Cancer 27item
  3. Colon Cancer 2item
  4. Colon Carcinoma 1 item
  5. Colorectal Cancer 3item
  6. Depression 1 item
  7. Diabetes 2item
  8. Glioma 1 item
  9. HIV Infections 2item
  10. Inflammatory Diseases 2item
  11. Lung Cancer 4item
  12. Mantle Cell Lymphoma 1 item
  13. Melanoma 3item
  14. Multiple Myeloma 4item
  15. Narcolepsy 1 item
  16. Neuroblastoma 1 item
  17. Non-small Cell Lung Cancer 2item
  18. Ovarian Cancer 3item
  19. Pancreatic Cancer 3item
  20. Prostate Cancer 3item
  21. Renal Cancer 1 item
  22. Renal Cell Carcinoma 1 item
  23. Sleep Disorders 2item
  24. Type 2 Diabetes 1 item